Frederick, United States
VaLogic Bio, founded in 2001, stands out as a dedicated player in the biotechnology industry, primarily in the United States. The company is renowned for its slogan, "Providing GMP/GxP compliance and technology solutions since 2001," reflecting its commitment to simplifying regulatory challenges for life science and biotech firms.
Specializing in advisory and compliance services, VaLogic Bio excels in offering consulting, software as a service (SaaS), and laboratory services. Their solutions encompass critical aspects from design and implementation to maintenance, including facilities and clean room design, integrated commissioning, quality systems, and risk management.
The company's proficiency in this niche space recently attracted investment interest, culminating in a Private Equity Round on November 29, 2023, led by 424 Capital. This investment underscores the confidence in VaLogic Bio's capabilities to drive regulatory excellence and operational innovation, making them a potential strategic asset in the life science sector.
MethodSense, Inc.